非ST段抬高急性冠脉综合征的抗栓治疗进展
被引量：1
摘要
抗栓药物在非ST段抬高型急性冠脉综合征患者中的应用大大减少了患者的死亡率、心肌梗死发生率。目前抗栓药物主要包括抗血小板和抗凝药,本文就这两类药物应用进展做一简要的综述。
出处
《临床药物治疗杂志》
2010年第2期17-22,共6页
Clinical Medication Journal
参考文献25
-
1Antithrombotic Trialists'Collaboration. Collaborative Metaanalysis of randomized trials of antiplateiet therapy for prevention of death, myocardial infarction, and stroke in high risk patients [ J ]. BMJ, 2002, 324(7329) : 71-86.
-
2Yusuf S, Zhao F, Mehta SR,et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST - segment elevation[J]. N Engl J Med,2002, 345(7) : 494-502.
-
3Steinhubl SR, Berger PB, Mann JT Ⅲ, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention : a randomized controlled trial[ J]. JAMA ,2002, 288 ( 19 ) : 2411 - 2420.
-
4Rioufo G, Gilard M, Finet G, et al. Evolution of spontaneous atherosclerotic plaque rupture with medical therapy : Long - term follow - up with intravascular ultrasound [ J ]. Circulation. 2004, 110 (18) :2875-2880.
-
5Mehta SR, Yusuf S, Peters R J, et al. Effects of pretreatment with clopidogrel undergoing study [ J ]. and aspirin followed by long - term therapy in patients percutaneous coronary intervention: the PCI - CURE Lancet ,2001, 358 ( 9281 ) : 527- 533.
-
6Wiviott SD, Antman EM, Winters K J, et al. JUMBO- TIMI 26 Investigators: Randomized comparison of prasugrel ( CS - 747, LY640315), a novel thienopyridine P2YI2 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint U- tilization of Medications to Block Platelets Optimally (JUMBO) - TIMI 26 trial[ J]. Circulation. 2005,111 (25) :3366- 3373.
-
7Kastrati A, Mehilli J, Sch"uhlen H, et al. Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment Study Investigators. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel[J]. N Engl J Med,2004, 350(3): 232-238.
-
8Kastrati A, Mehilli J, Neumann FJ, et al. Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 ( ISAR - REACT 2 ) Trial Investigators. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: The ISAR - RE- ACT2 randomized trial[J]. JAMA,2006, 295( 13): 1531- 1538.
-
9Gurbel PA, Bliden KP, Hayes KM, et al. The relation of dosing to clopidogrel responsiveness and the incidence of high posttreatment platelet aggregation in patients undergoing coronary stenting[J]. J Am Coil Cardiol,2005,45(9) : 1392-1396.
-
10Dalby M, Montalescot G, dit Sollier CB, et al. Eptifibatide provides additional platelet inhibition in non - ST - elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non - Q - wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) study[J]. J Am Coll Cardiol,2004, 43(2) : 162- 168.
同被引文献3
-
1吕树铮.非ST段抬高急性冠脉综合征优化治疗策略[J].中国心血管病研究,2009,7(9):641-642. 被引量：7
-
2彭长农,胡雪松,方卫华,衣为民,刘幼文,刘强,龙娟,李忠红,金光临.非ST段抬高急性冠脉综合征的早期介入治疗研究[J].中国基层医药,2004,11(7):777-778. 被引量：2
-
3高爱玲,张素清,乔亚京,逯保军,韩雪梅,陈旭红.盐酸替罗非班治疗急性冠状动脉综合征的安全性和有效性评价[J].中国实用医刊,2009,36(2):58-59. 被引量：1
-
1郭燕鸽.氯吡格雷、阿司匹林和低分子肝素三联治疗非ST段抬高型急性冠脉综合征疗效观察[J].医学研究通讯,2005,34(12):77-77.
-
2高海英,米纪平.氯吡格雷、阿司匹林和依诺肝素三联治疗非ST段抬高型急性冠脉综合征疗效观察[J].疑难病杂志,2005,4(3):159-160. 被引量：4
-
3王长宏,刘向荣,赵树华.丹红注射液治疗非ST段抬高型急性冠脉综合征26例临床观察[J].山东医药,2009,49(32):112-112.
-
4李松杨.急性重度镇静催眠药中毒的抢救体会[J].新医学,1994,25(12):622-624. 被引量：3
-
5孙晓红.安眠药中毒急救护理体会[J].工企医刊,2003,16(1):110-110.
-
6曲西宏,牛长斌.非ST段抬高型急性冠脉综合征90例临床治疗观察[J].中国临床实用医学,2010(2):126-127.
-
7王慧媛,陈丽.慢性心力衰竭药物治疗研究进展[J].中国药房,2005,16(20):1587-1589. 被引量：4
-
8郭攀,王平,毛治尉,孙漾丽.磺达肝癸钠治疗高出血风险急性冠脉综合征的疗效观察[J].中华全科医学,2013,11(9):1350-1351. 被引量：1
-
9石闺英,郑剑,曾进荣,陈引香,喻国琼.低分子肝素钙加舒血宁治疗不稳定型心绞痛疗效观察[J].人民军医,2007,50(7):415-416. 被引量：3
-
10袁志敏.减少出血可改善非ST段抬高型急性冠脉综合征患者临床预后[J].国际老年医学杂志,2010,31(1):46-46.
